Prospects for a comprehensive assessment of sclerostin, arterial calcification and stiffness in the context of coronary heart disease
Abstract
Background. Coronary heart disease is accompanied by increased calcification and vascular stiffness, which is associated with an increased risk of adverse cardiovascular events. This manuscript focuses on the contribution of sclerostin to the development of vascular calcification and arterial stiffness, which is a key aspect of coronary heart disease.
Purpose. To assess the possibility of developing a comprehensive approach to assessing the likelihood of vascular calcification, taking into account indicators of arterial stiffness and a marker of extraosseous calcification (sclerostin) to improve noninvasive diagnostics of cardiovascular risk.
Materials and methods. The study included patients with myocardial infarction and unstable angina. Arterial stiffness index and calcification were assessed taking into account coronary angiography data and 24-hour blood pressure monitoring. Serum sclerostin concentrations were measured using ELISA.
Results. An increase in sclerostin concentration was found in patients with coronary artery stenosis of more than 50% in combination with intravascular calcified atherosclerotic plaques. A strong correlation was found between serum sclerostin concentration and arterial stiffness index. Results on a significant increase in the arterial stiffness index against the background of coronary artery calcification were obtained. The results of ROC analysis showed the possibility of using threshold value of arterial stiffness index in assessing the severity of coronary artery disease.
Conclusion. Understanding the relationship between sclerostin, calcification and vascular stiffness can help in the development of new strategies for the diagnosis, prevention and treatment of coronary artery disease.
Sponsorship information. The work was done at the Orel State University named after I.S. Turgenev (Russia) within the framework of the state assignment No. 075-00196-24-08 for 2024 and for the planning period of 2025 and 2026 since 08/23/2024, project № FSGN-2024-0014 (1024041900023-6-1.2.1;2.6.2;3.1.3;3.2.12;3.2.4).
EDN: NXRFOQ
Downloads
References
Brandenburg, V. M., Kramann, R., Koos, R., Krüger, T., Schurgers, L., Mühlenbruch, G., Hübner, S., Gladziwa, U., Drechsler, C., & Ketteler, M. (2013). Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study. BMC Nephrology, 14, 219. https://doi.org/10.1186/1471-2369-14-219 EDN: https://elibrary.ru/gzbmxs
Ceccherini, E., Cecchettini, A., Gisone, I., Persiani, E., Morales, M. A., & Vozzi, F. (2022). Vascular Calcification: In Vitro Models under the Magnifying Glass. Biomedicines, 10(10), 2491. https://doi.org/10.3390/biomedicines10102491 EDN: https://elibrary.ru/disuyh
Chen, Y., Zhao, X., & Wu, H. (2020). Arterial Stiffness: A Focus on Vascular Calcification and Its Link to Bone Mineralization. Arteriosclerosis, Thrombosis, and Vascular Biology, 40(5), 1078-1093. https://doi.org/10.1161/ATVBAHA.120.313131 EDN: https://elibrary.ru/dtcvyk
Demer, L. L., & Tintut, Y. (2008). Vascular calcification: pathobiology of a multifaceted disease. Circulation, 117(22), 2938-2948. https://doi.org/10.1161/CIRCULATIONAHA.107.743161 EDN: https://elibrary.ru/mmgbvr
Durham, A. L., Speer, M. Y., Scatena, M., Giachelli, C. M., & Shanahan, C. M. (2018). Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovascular Research, 114(4), 590-600. https://doi.org/10.1093/cvr/cvy010
Figurek, A., & Spasovski, G. (2018). Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease-mineral and bone disorder? International Urology and Nephrology, 50(10), 1863-1870. https://doi.org/10.1007/s11255-018-1935-5 EDN: https://elibrary.ru/oanvkd
Gao, L., Lu, D., Xia, G., et al. (2021). The relationship between arterial stiffness index and coronary heart disease and its severity. BMC Cardiovascular Disorders, 21, 527. https://doi.org/10.1186/s12872-021-02350-6 EDN: https://elibrary.ru/hlxrmh
Golledge, J., & Thanigaimani, S. (2022). Role of Sclerostin in Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 42(7), e187-e202. https://doi.org/10.1161/ATVBAHA.122.317635 EDN: https://elibrary.ru/jtlerh
Gui, Z., Shao, C., Zhan, Y., Wang, Z., & Li, L. (2024). Vascular calcification: High incidence sites, distribution, and detection. Cardiovascular Pathology, 72, 107667. https://doi.org/10.1016/j.carpath.2024.107667 EDN: https://elibrary.ru/qzdifq
Hampson, G., Edwards, S., Conroy, S., Blake, G. M., Fogelman, I., & Frost, M. L. (2013). The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. Bone, 56(1), 42-47. https://doi.org/10.1016/j.bone.2013.05.010
Hata, Y., Mochizuki, J., Okamoto, S., Matsumi, H., & Hashimoto, K. (2022). Aortic calcification is associated with coronary artery calcification and is a potential surrogate marker for ischemic heart disease risk: A cross-sectional study. Medicine, 101(29), e29875. https://doi.org/10.1097/MD.0000000000029875 EDN: https://elibrary.ru/yhytxe
Kadıoğlu, A., & Bahadır, S. (2022). Breast arterial calcifications as an indicator of atherosclerotic cardiovascular disease: comparative analysis of coronary computed tomography scoring systems and carotid intima-media thickness. Quantitative Imaging in Medicine and Surgery, 12(1), 457-469. https://doi.org/10.21037/qims-21-98 EDN: https://elibrary.ru/yyftdo
Koos, R., Brandenburg, V., Mahnken, A. H., Schneider, R., Dohmen, G., Autschbach, R., Marx, N., & Kramann, R. (2013). Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study. The Journal of Heart Valve Disease, 22(3), 317-325.
Lee, S. J., Lee, I. K., & Jeon, J. H. (2020). Vascular Calcification-New Insights Into Its Mechanism. International Journal of Molecular Sciences, 21(8), 2685. https://doi.org/10.3390/ijms21082685 EDN: https://elibrary.ru/joqymx
Mack, C. P. (2011). Signaling mechanisms that regulate smooth muscle cell differentiation. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(7), 1495-1505. https://doi.org/10.1161/ATVBAHA.110.221135
Mozos, I., Malainer, C., Horbańczuk, J., Gug, C., Stoian, D., Luca, C. T., & Atanasov, A. G. (2017). Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases. Frontiers in Immunology, 8, 1058. https://doi.org/10.3389/fimmu.2017.01058
Ortega, M. A., De Leon-Oliva, D., Gimeno-Longas, M. J., Boaru, D. L., Fraile-Martinez, O., García-Montero, C., de Castro, A. V., Barrena-Blázquez, S., López-González, L., Amor, S., García-Honduvilla, N., Buján, J., Guijarro, L. G., Castillo-Ruiz, E., Álvarez-Mon, M. Á., Albillos, A., Álvarez-Mon, M., Diaz, R., & Saez, M. A. (2024). Vascular Calcification: Molecular Networking, Pathological Implications and Translational Opportunities. Biomolecules, 14(3), 275. https://doi.org/10.3390/biom14030275 EDN: https://elibrary.ru/tbtxgc
Popovic, D. S., Mitrovic, M., Tomic-Naglic, D., Icin, T., Bajkin, I., Vukovic, B., Benc, D., Zivanovic, Z., Kovacev-Zavisic, B., & Stokic, E. (2017). The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in Obesity. Current Neurovascular Research, 14(3), 200-206. https://doi.org/10.2174/1567202614666170619080526 EDN: https://elibrary.ru/yhxvlc
Rennenberg, R. J., Kessels, A. G., Schurgers, L. J., van Engelshoven, J. M., de Leeuw, P. W., & Kroon, A. A. (2009). Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vascular Health and Risk Management, 5(1), 185-197. https://doi.org/10.2147/vhrm.s4822 EDN: https://elibrary.ru/nakwvx
Snimshchikova, I. A., & Plotnikova, M. O. (2023). Role of morphogenic proteins of the WNT signaling pathway in coronary artery disease. Medical Immunology (Russia), 25(4), 985-990. https://doi.org/10.15789/1563-0625-ROM-2835 EDN: https://elibrary.ru/ppgrow
Sutton, N. R., Malhotra, R., St Hilaire, C., Aikawa, E., Blumenthal, R. S., Gackenbach, G., Goyal, P., Johnson, A., Nigwekar, S. U., Shanahan, C. M., Towler, D. A., Wolford, B. N., & Chen, Y. (2023). Molecular Mechanisms of Vascular Health: Insights From Vascular Aging and Calcification. Arteriosclerosis, Thrombosis, and Vascular Biology, 43(1), 15-29. https://doi.org/10.1161/ATVBAHA.122.317332 EDN: https://elibrary.ru/jscdmh
Toussaint, N. D., Lau, K. K., Strauss, B. J., Polkinghorne, K. R., & Kerr, P. G. (2008). Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrology, Dialysis, Transplantation, 23(2), 586-593. https://doi.org/10.1093/ndt/gfm660 EDN: https://elibrary.ru/ixuljd
van der Toorn, J. E., Bos, D., Arshi, B., Leening, M. J. G., Vernooij, M. W., Ikram, M. A., Ikram, M. K., & Kavousi, M. (2021). Arterial calcification at different sites and prediction of atherosclerotic cardiovascular disease among women and men. Atherosclerosis, 337, 27-34. https://doi.org/10.1016/j.atherosclerosis.2021.10.009 EDN: https://elibrary.ru/bogovk
Wang, X.-R., Yuan, L., Zhang, J.-J., Hao, L., & Wang, D.-G. (2017). Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D. Nephrology, 22(4), 286-292. https://doi.org/10.1111/NEP.12813
Yang, S., Zeng, Z., Yuan, Q., Chen, Q., Wang, Z., Xie, H., & Liu, J. (2023). Vascular calcification: from the perspective of crosstalk. Molecular Biomedicine, 4(1), 35. https://doi.org/10.1186/s43556-023-00146-y EDN: https://elibrary.ru/vivgbl
Yu, Q., Li, W., Xie, D., Zheng, X., Huang, T., Xue, P., Guo, B., Gao, Y., Zhang, C., Sun, P., Li, M., Wang, G., Cheng, X., Zheng, Q., & Song, Z. (2018). PI3Kγ promotes vascular smooth muscle cell phenotypic modulation and transplant arteriosclerosis via a SOX9-dependent mechanism. EBioMedicine, 36, 39-53. https://doi.org/10.1016/j.ebiom.2018.09.013
Copyright (c) 2025 Irina A. Snimshchikova, Maria O. Revyakina, Natalia A. Kabina, Ekaterina V. Mityaeva
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
